A Study of MD-120 in Patients With Depression

NCT04345471 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

615

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Desvenlafaxine 100 mg
DRUG: Desvenlafaxine 50 mg
DRUG: Placebo

Sponsor

Mochida Pharmaceutical Company, Ltd.

Collaborators

[object Object]